178 related articles for article (PubMed ID: 10747827)
1. Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia.
Rodríguez-Hernández MJ; Pachón J; Pichardo C; Cuberos L; Ibáñez-Martínez J; García-Curiel A; Caballero FJ; Moreno I; Jiménez-Mejías ME
J Antimicrob Chemother; 2000 Apr; 45(4):493-501. PubMed ID: 10747827
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia.
Bernabeu-Wittel M; Pichardo C; García-Curiel A; Pachón-Ibáñez ME; Ibáñez-Martínez J; Jiménez-Mejías ME; Pachón J
Clin Microbiol Infect; 2005 Apr; 11(4):319-25. PubMed ID: 15760430
[TBL] [Abstract][Full Text] [Related]
3. In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia.
Joly-Guillou ML; Wolff M; Farinotti R; Bryskier A; Carbon C
J Antimicrob Chemother; 2000 Nov; 46(5):827-30. PubMed ID: 11062208
[TBL] [Abstract][Full Text] [Related]
4. Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem.
Joly-Guillou ML; Wolff M; Pocidalo JJ; Walker F; Carbon C
Antimicrob Agents Chemother; 1997 Feb; 41(2):345-51. PubMed ID: 9021190
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.
Tang HJ; Chuang YC; Ko WC; Chen CC; Shieh JM; Chen CH; Lee NY; Chiang SR
Int J Infect Dis; 2012 Jan; 16(1):e34-40. PubMed ID: 22088863
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii.
Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Ardanuy C; Gudiol F
Antimicrob Agents Chemother; 2002 Jun; 46(6):1946-52. PubMed ID: 12019113
[TBL] [Abstract][Full Text] [Related]
8. Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains.
Rodríguez-Hernández MJ; Cuberos L; Pichardo C; Caballero FJ; Moreno I; Jiménez-Mejías ME; García-Curiel A; Pachón J
J Antimicrob Chemother; 2001 Apr; 47(4):479-82. PubMed ID: 11266426
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii.
Pachón-Ibáñez ME; Docobo-Pérez F; López-Rojas R; Domínguez-Herrera J; Jiménez-Mejias ME; García-Curiel A; Pichardo C; Jiménez L; Pachón J
Antimicrob Agents Chemother; 2010 Mar; 54(3):1165-72. PubMed ID: 20047914
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Borraz C; Gudiol F
J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972
[TBL] [Abstract][Full Text] [Related]
11. Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam.
Pachón-Ibáñez ME; Fernández-Cuenca F; Docobo-Pérez F; Pachón J; Pascual A
J Antimicrob Chemother; 2006 Sep; 58(3):689-92. PubMed ID: 16870647
[TBL] [Abstract][Full Text] [Related]
12. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
Mimoz O; Elhelali N; Léotard S; Jacolot A; Laurent F; Samii K; Petitjean O; Nordmann P
J Antimicrob Chemother; 1999 Jul; 44(1):91-7. PubMed ID: 10459815
[TBL] [Abstract][Full Text] [Related]
13. In Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii.
Yang YS; Lee Y; Tseng KC; Huang WC; Chuang MF; Kuo SC; Lauderdale TL; Chen TL
Antimicrob Agents Chemother; 2016 Jul; 60(7):4047-54. PubMed ID: 27114274
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of human simulated epithelial lining fluid concentrations of amikacin inhale alone and in combination with meropenem against Acinetobacter baumannii.
Ghazi IM; Grupper M; Nicolau DP
Infect Dis (Lond); 2017; 49(11-12):831-839. PubMed ID: 28758820
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of tigecycline vs. imipenem in the treatment of experimental Acinetobacter baumannii murine pneumonia.
Pichardo C; Pachón-Ibañez ME; Docobo-Perez F; López-Rojas R; Jiménez-Mejías ME; Garcia-Curiel A; Pachon J
Eur J Clin Microbiol Infect Dis; 2010 May; 29(5):527-31. PubMed ID: 20182760
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Zhao C; Xie W; Zhang W; Ye Z; Wu H
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
[TBL] [Abstract][Full Text] [Related]
18. Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases.
Özvatan T; Akalın H; Sınırtaş M; Ocakoğlu G; Yılmaz E; Heper Y; Kelebek N; İşçimen R; Kahveci F
Respirology; 2016 Feb; 21(2):363-9. PubMed ID: 26635315
[TBL] [Abstract][Full Text] [Related]
19. Rapid imipenem/cilastatin desensitization for multidrug-resistant Acinetobacter pneumonia.
Gorman SK; Zed PJ; Dhingra VK; Ronco JJ
Ann Pharmacother; 2003 Apr; 37(4):513-6. PubMed ID: 12659606
[TBL] [Abstract][Full Text] [Related]
20. The effect of amikacin and imipenem alone and in combination against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
Máthé A; Szabó D; Anderlik P; Rozgonyi F; Nagy K
Diagn Microbiol Infect Dis; 2007 May; 58(1):105-10. PubMed ID: 17300908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
